Details werden geladen...
FDA Approves Efsitora Once-Weekly Basal Insulin Injection
The approval adds a second long-acting, injectable option for the treatment of type 2 diabetes.
Ähnliche Seiten
FDA approves Eli Lilly's Onswik once-weekly insulin injection for type 2 diabetes
https://nypost.com/2026/09/24/business/fda-approves-eli-lillys-onswik-once-weekly-insulin-injection-for-type-2-diabetes/
Novo Nordisk launches 'Awiqli' once-weekly basal insulin injection for diabetes in India - Rediff.com Business
https://www.rediff.com/business/report/novo-nordisk-launches-awiqli-once-weekly-basal-insulin-injection-for-diabetes-in-india/20260709.htm
Novo Nordisk India launches Awiqli: Once a week insulin injection can finally make diabetes easier to live with - India Today
https://www.indiatoday.in/health/story/once-weekly-insulin-india-novo-nordisk-awiqli-type-1-type-2-diabetes-2944260-2026-07-10
Dysesthesia Risk Appears to Rise With GLP-1s
https://www.medscape.com/viewarticle/dysesthesia-risk-appears-rise-glp-1s-2026a1000y6z
FDA approves new treatment for those with advanced pancreatic cancer - UPI.com
https://www.upi.com/Top_News/US/2026/08/26/FDA-approved-new-pancreatic-cancer-treatment/8471787771334/